Telangana: DCA Raids Uncover Fake Medicines, Unlicensed Clinics

Hyderabad: The Drugs Control Administration (DCA) of Warangal Zone conducted several raids on Tuesday, August 27 and Wednesday, August 28 that uncovered several violations, like illegal manufacture and sale of drugs mislabeled as ‘food products/nutraceuticals.’

The product, ‘Fer-XT Tablets’ (Ferrous Ascorbate and Folic Acid Tablets), was falsely marketed as a food product/nutraceutical under an FSSAI license.

The tablets claimed to contain 100 mg of ferrous ascorbate and 1.5 mg of folic acid, were illegally produced at Alfansa Bio Pvt Ltd in Hyderabad. They were then marketed by Phelix Health Care in New Delhi.

According to the label, the product should be classified as a drug under the Drugs and Cosmetics Act and must be manufactured under a proper drug license, adhering to Good Manufacturing Practices (GMP) and quality standards set by the Indian Pharmacopoeia (IP).

Drugs inspector P Pavani led the raid and seized the tablets at a medical shop in Karimnagar. Samples were collected for further analysis.

Seizure over misleading advertisements
In a separate operation, DCA officials targeted medicines, making misleading claims about treating ‘Peptic Ulcer’ and ‘Fever’. These claims are banned under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

The products seized included Coolsure Plus Suspension (Allopathic), which falsely claimed to treat peptic ulcers. Manufactured by Aspen Life Sciences in Amritsar, it was found in Mailardevpally, Rangareddy district. Another product, Bhringaraja Churnam (Ayurvedic), was advertised for fever treatment. It was manufactured by Samraksha Ayurvedic Pharmacy in Kukatpally and detected in Prashanthi Nagar.

The advertisements violate the Act, which prohibits such claims and could lead to penalties including imprisonment for up to six months or fines.

Raid on quacks
On August 27, DCA officials raided the clinic of Devaji Vilas Patil, a quack practising without proper qualifications at Santosh Clinic in Jagathgiri Gutta, Medchal-Malkajgiri district.

The raid revealed 32 varieties of unlicensed medicines, including antibiotics and steroids, with a total value of Rs 15,000. The indiscriminate sale of these medicines poses severe health risks, including antimicrobial resistance and adverse effects from steroid misuse.

Officials, led by E Thirupathi and other inspectors, seized the stock and samples for further analysis. Further investigation is underway.

DCA has urged citizens to report any suspected illegal drug manufacturing or distribution activities to the DCA Telangana toll-free number: 1800-599-6969, available from 10:30 am to 5:00 pm on working days.

Related Posts

  • Pharma
  • January 21, 2025
  • 9 views
Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister Narendra Modi’s budget…

  • Pharma
  • January 21, 2025
  • 27 views
Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharmaceuticals share price:Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.23 per cent to hit an intraday high of Rs 1,537.90 per share on Tuesday, January 21, 2025. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Biocon urges govt to exempt cancer, rare-disease drugs from tax in Budget

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Glenmark Pharma share rises 2% as unit launches blood clotting drug

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Fire breaks out at pharmaceutical company in Andhra Pradesh, no casualty

Pharma body to cap prices of cigarette substitutes, seeks data

Pharma body to cap prices of cigarette substitutes, seeks data

Budget 2025: Pharma industry lays out a plan to curb Chinese dependence

Budget 2025: Pharma industry lays out a plan to curb Chinese dependence

Aurobindo Pharma Ltd rises for third straight session

Aurobindo Pharma Ltd rises for third straight session